Results 231 to 240 of about 2,574,537 (354)

Local Tetrahydrobiopterin Administration Augments Reflex Cutaneous Vasodilation Through Nitric Oxide-Dependent Mechanisms In Aged Human Skin

Stanhewicz, Anna E., Bruning, Rebecca S., Smith, Caroline J., Kenney, W. Larry, Holowatz, Lacy A.   +4 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Severe systemic cutaneous adverse reactions following camrelizumab therapy: a case report and literature review. [PDF]

Front Immunol
Sun YD, Guo WJ, Han JJ.
europepmc   +1 more source

Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma

Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley   +1 more source

Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

Arthritis &Rheumatology, Accepted Article.
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Sprayable Cellulose and Mannan Nanocrystals from Ivory Nuts for Treatment of Skin Diseases in Mice. [PDF]

ACS Appl Bio Mater
da Rocha VME, Wille APB, Silva APSE, Gularte MS, Soares MP, Silveira MM, Giongo J, Vaucher RA, Spitzner JR, Fajardo AR, Carvajal Barriga EJ, Wilhelm EA.   +11 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Familial cluster of cutaneous anthrax in North Khorasan, Iran: A case series and public health reflection. [PDF]

IDCases
Arian M, Naqvi SM, Niazirad N, Torshizi AJ, Mohammadi A, Ketabi K.   +5 more
europepmc   +1 more source

Variations in cutaneous zinc concentrations after oral administration of zinc gluconate

, 1984
Brigitte Dréno, Stalder Jf, C. Pecquet, H Boiteau, H Barrière   +4 more
openalex   +2 more sources

Oral l‐glutamine administration attenuated cutaneous wound healing in Wistar rats

International Wound Journal, 2016
Saurabh Goswami, A. Kandhare, A. Zanwar, M. Hegde, S. Bodhankar, Sudhir Shinde, Shahaji Deshmukh, R. Kharat   +7 more
semanticscholar   +1 more source